カテゴリー： Market Monitor Global, 世界, 医療/バイオ

抗うつ剤の世界市場見通し2023年-2029年

◆英語タイトル：Anti-depressant Drugs Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5676）

◆商品コード：MMG23JU5676
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月（※2025年版があります。お問い合わせください。）
◆ページ数：78
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥468,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥608,400	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥702,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Anti-depressant Drugs Market 調査レポートは次の情報を含め、グローバルにおけるの抗うつ剤市場規模と予測を収録しています。・世界の抗うつ剤市場：売上、2018年-2023年、2024年-2029年
・世界の抗うつ剤市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の抗うつ剤市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「選択的セロトニン再取り込み阻害剤（SSRI）」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

抗うつ剤のグローバル主要企業は、Alkermes、 Allergan、 Bristol-Myers Squibb、 Eli Lilly and Company、 GlaxoSmithKline、 Lundbeck、 Merck、 Pfizer、 Teva Pharmaceutical Industries、 Takeda Pharmaceutical Company、 AstraZeneca、 Johnson and Johnson、 Sanofi、 Sun Pharmaceuticalsなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、抗うつ剤のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の抗うつ剤市場：タイプ別、2018年-2023年、2024年-2029年
世界の抗うつ剤市場：タイプ別市場シェア、2022年
・選択的セロトニン再取り込み阻害剤（SSRI）、セロトニン・ノルアドレナリン再取り込み阻害剤（SNRI）、三環系抗うつ薬（TCA）、モノアミンオキシダーゼ阻害剤（MAOI）、その他

世界の抗うつ剤市場：用途別、2018年-2023年、2024年-2029年
世界の抗うつ剤市場：用途別市場シェア、2022年
・大うつ病性障害、強迫性障害、全般性不安障害、パニック障害、その他

世界の抗うつ剤市場：地域・国別、2018年-2023年、2024年-2029年
世界の抗うつ剤市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における抗うつ剤のグローバル売上、2018年-2023年
・主要企業における抗うつ剤のグローバル売上シェア、2022年
・主要企業における抗うつ剤のグローバル販売量、2018年-2023年
・主要企業における抗うつ剤のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Alkermes、 Allergan、 Bristol-Myers Squibb、 Eli Lilly and Company、 GlaxoSmithKline、 Lundbeck、 Merck、 Pfizer、 Teva Pharmaceutical Industries、 Takeda Pharmaceutical Company、 AstraZeneca、 Johnson and Johnson、 Sanofi、 Sun Pharmaceuticals

*************************************************************

・調査・分析レポートの概要
抗うつ剤市場の定義
市場セグメント
世界の抗うつ剤市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の抗うつ剤市場規模
世界の抗うつ剤市場規模：2022年 VS 2029年
世界の抗うつ剤市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの抗うつ剤の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の抗うつ剤製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：選択的セロトニン再取り込み阻害剤（SSRI）、セロトニン・ノルアドレナリン再取り込み阻害剤（SNRI）、三環系抗うつ薬（TCA）、モノアミンオキシダーゼ阻害剤（MAOI）、その他
抗うつ剤のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：大うつ病性障害、強迫性障害、全般性不安障害、パニック障害、その他
抗うつ剤の用途別グローバル売上・予測

・地域別市場分析
地域別抗うつ剤市場規模 2022年と2029年
地域別抗うつ剤売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Alkermes、 Allergan、 Bristol-Myers Squibb、 Eli Lilly and Company、 GlaxoSmithKline、 Lundbeck、 Merck、 Pfizer、 Teva Pharmaceutical Industries、 Takeda Pharmaceutical Company、 AstraZeneca、 Johnson and Johnson、 Sanofi、 Sun Pharmaceuticals
...

Antidepressants are drugs used for the treatment of major depressive disorder and other conditions, including dysthymia, anxiety disorders, obsessive–compulsive disorder, eating disorders, chronic pain, neuropathic pain and, in some cases, dysmenorrhoea, snoring, migraine, attention-deficit hyperactivity disorder (ADHD), addiction, dependence, and sleep disorders. They may be prescribed alone or in combination with other medications.
This report aims to provide a comprehensive presentation of the global market for Anti-depressant Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-depressant Drugs. This report contains market size and forecasts of Anti-depressant Drugs in global, including the following market information:
Global Anti-depressant Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Anti-depressant Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Anti-depressant Drugs companies in 2022 (%)
The global Anti-depressant Drugs market was valued at US$ 12590 million in 2022 and is projected to reach US$ 14950 million by 2029, at a CAGR of 2.5% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Anti-depressant Drugs Market by Depressive Disorder (Major Depressive Disorder, Obsessive-Compulsive Disorder, Generalized Anxiety Disorder, Panic Disorder, and Others) and Product (Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, Monoamine Oxidase Inhibitors, Serotonin Antagonist and Reuptake Inhibitors, and Others)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anti-depressant Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti-depressant Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Anti-depressant Drugs Market Segment Percentages, by Type, 2022 (%)
Selective Serotonin Reuptake Inhibitor (SSRI)
Serotonin-Norepinephrine Reuptake Inhibitor (SNRI)
Tricyclic Antidepressant (TCA)
Monoamine Oxidase Inhibitor (MAOI)
Others
Global Anti-depressant Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Anti-depressant Drugs Market Segment Percentages, by Application, 2022 (%)
Major Depressive Disorder
Obsessive-Compulsive Disorder
Generalized Anxiety Disorder
Panic Disorder
Others
Global Anti-depressant Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Anti-depressant Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti-depressant Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Anti-depressant Drugs revenues share in global market, 2022 (%)
Key companies Anti-depressant Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Anti-depressant Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Alkermes
Allergan
Bristol-Myers Squibb
Eli Lilly and Company
GlaxoSmithKline
Lundbeck
Merck
Pfizer
Teva Pharmaceutical Industries
Takeda Pharmaceutical Company
AstraZeneca
Johnson and Johnson
Sanofi
Sun Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Anti-depressant Drugs, market overview.
Chapter 2: Global Anti-depressant Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Anti-depressant Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Anti-depressant Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Anti-depressant Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Anti-depressant Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anti-depressant Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anti-depressant Drugs Overall Market Size
2.1 Global Anti-depressant Drugs Market Size: 2022 VS 2029
2.2 Global Anti-depressant Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Anti-depressant Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Anti-depressant Drugs Players in Global Market
3.2 Top Global Anti-depressant Drugs Companies Ranked by Revenue
3.3 Global Anti-depressant Drugs Revenue by Companies
3.4 Global Anti-depressant Drugs Sales by Companies
3.5 Global Anti-depressant Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Anti-depressant Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Anti-depressant Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Anti-depressant Drugs Players in Global Market
3.8.1 List of Global Tier 1 Anti-depressant Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Anti-depressant Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Anti-depressant Drugs Market Size Markets, 2022 & 2029
4.1.2 Selective Serotonin Reuptake Inhibitor (SSRI)
4.1.3 Serotonin-Norepinephrine Reuptake Inhibitor (SNRI)
4.1.4 Tricyclic Antidepressant (TCA)
4.1.5 Monoamine Oxidase Inhibitor (MAOI)
4.1.6 Others
4.2 By Type – Global Anti-depressant Drugs Revenue & Forecasts
4.2.1 By Type – Global Anti-depressant Drugs Revenue, 2018-2023
4.2.2 By Type – Global Anti-depressant Drugs Revenue, 2024-2029
4.2.3 By Type – Global Anti-depressant Drugs Revenue Market Share, 2018-2029
4.3 By Type – Global Anti-depressant Drugs Sales & Forecasts
4.3.1 By Type – Global Anti-depressant Drugs Sales, 2018-2023
4.3.2 By Type – Global Anti-depressant Drugs Sales, 2024-2029
4.3.3 By Type – Global Anti-depressant Drugs Sales Market Share, 2018-2029
4.4 By Type – Global Anti-depressant Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Anti-depressant Drugs Market Size, 2022 & 2029
5.1.2 Major Depressive Disorder
5.1.3 Obsessive-Compulsive Disorder
5.1.4 Generalized Anxiety Disorder
5.1.5 Panic Disorder
5.1.6 Others
5.2 By Application – Global Anti-depressant Drugs Revenue & Forecasts
5.2.1 By Application – Global Anti-depressant Drugs Revenue, 2018-2023
5.2.2 By Application – Global Anti-depressant Drugs Revenue, 2024-2029
5.2.3 By Application – Global Anti-depressant Drugs Revenue Market Share, 2018-2029
5.3 By Application – Global Anti-depressant Drugs Sales & Forecasts
5.3.1 By Application – Global Anti-depressant Drugs Sales, 2018-2023
5.3.2 By Application – Global Anti-depressant Drugs Sales, 2024-2029
5.3.3 By Application – Global Anti-depressant Drugs Sales Market Share, 2018-2029
5.4 By Application – Global Anti-depressant Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Anti-depressant Drugs Market Size, 2022 & 2029
6.2 By Region – Global Anti-depressant Drugs Revenue & Forecasts
6.2.1 By Region – Global Anti-depressant Drugs Revenue, 2018-2023
6.2.2 By Region – Global Anti-depressant Drugs Revenue, 2024-2029
6.2.3 By Region – Global Anti-depressant Drugs Revenue Market Share, 2018-2029
6.3 By Region – Global Anti-depressant Drugs Sales & Forecasts
6.3.1 By Region – Global Anti-depressant Drugs Sales, 2018-2023
6.3.2 By Region – Global Anti-depressant Drugs Sales, 2024-2029
6.3.3 By Region – Global Anti-depressant Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Anti-depressant Drugs Revenue, 2018-2029
6.4.2 By Country – North America Anti-depressant Drugs Sales, 2018-2029
6.4.3 US Anti-depressant Drugs Market Size, 2018-2029
6.4.4 Canada Anti-depressant Drugs Market Size, 2018-2029
6.4.5 Mexico Anti-depressant Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Anti-depressant Drugs Revenue, 2018-2029
6.5.2 By Country – Europe Anti-depressant Drugs Sales, 2018-2029
6.5.3 Germany Anti-depressant Drugs Market Size, 2018-2029
6.5.4 France Anti-depressant Drugs Market Size, 2018-2029
6.5.5 U.K. Anti-depressant Drugs Market Size, 2018-2029
6.5.6 Italy Anti-depressant Drugs Market Size, 2018-2029
6.5.7 Russia Anti-depressant Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Anti-depressant Drugs Market Size, 2018-2029
6.5.9 Benelux Anti-depressant Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Anti-depressant Drugs Revenue, 2018-2029
6.6.2 By Region – Asia Anti-depressant Drugs Sales, 2018-2029
6.6.3 China Anti-depressant Drugs Market Size, 2018-2029
6.6.4 Japan Anti-depressant Drugs Market Size, 2018-2029
6.6.5 South Korea Anti-depressant Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Anti-depressant Drugs Market Size, 2018-2029
6.6.7 India Anti-depressant Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Anti-depressant Drugs Revenue, 2018-2029
6.7.2 By Country – South America Anti-depressant Drugs Sales, 2018-2029
6.7.3 Brazil Anti-depressant Drugs Market Size, 2018-2029
6.7.4 Argentina Anti-depressant Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Anti-depressant Drugs Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Anti-depressant Drugs Sales, 2018-2029
6.8.3 Turkey Anti-depressant Drugs Market Size, 2018-2029
6.8.4 Israel Anti-depressant Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Anti-depressant Drugs Market Size, 2018-2029
6.8.6 UAE Anti-depressant Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Alkermes
7.1.1 Alkermes Company Summary
7.1.2 Alkermes Business Overview
7.1.3 Alkermes Anti-depressant Drugs Major Product Offerings
7.1.4 Alkermes Anti-depressant Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Alkermes Key News & Latest Developments
7.2 Allergan
7.2.1 Allergan Company Summary
7.2.2 Allergan Business Overview
7.2.3 Allergan Anti-depressant Drugs Major Product Offerings
7.2.4 Allergan Anti-depressant Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Allergan Key News & Latest Developments
7.3 Bristol-Myers Squibb
7.3.1 Bristol-Myers Squibb Company Summary
7.3.2 Bristol-Myers Squibb Business Overview
7.3.3 Bristol-Myers Squibb Anti-depressant Drugs Major Product Offerings
7.3.4 Bristol-Myers Squibb Anti-depressant Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Bristol-Myers Squibb Key News & Latest Developments
7.4 Eli Lilly and Company
7.4.1 Eli Lilly and Company Company Summary
7.4.2 Eli Lilly and Company Business Overview
7.4.3 Eli Lilly and Company Anti-depressant Drugs Major Product Offerings
7.4.4 Eli Lilly and Company Anti-depressant Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Eli Lilly and Company Key News & Latest Developments
7.5 GlaxoSmithKline
7.5.1 GlaxoSmithKline Company Summary
7.5.2 GlaxoSmithKline Business Overview
7.5.3 GlaxoSmithKline Anti-depressant Drugs Major Product Offerings
7.5.4 GlaxoSmithKline Anti-depressant Drugs Sales and Revenue in Global (2018-2023)
7.5.5 GlaxoSmithKline Key News & Latest Developments
7.6 Lundbeck
7.6.1 Lundbeck Company Summary
7.6.2 Lundbeck Business Overview
7.6.3 Lundbeck Anti-depressant Drugs Major Product Offerings
7.6.4 Lundbeck Anti-depressant Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Lundbeck Key News & Latest Developments
7.7 Merck
7.7.1 Merck Company Summary
7.7.2 Merck Business Overview
7.7.3 Merck Anti-depressant Drugs Major Product Offerings
7.7.4 Merck Anti-depressant Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Merck Key News & Latest Developments
7.8 Pfizer
7.8.1 Pfizer Company Summary
7.8.2 Pfizer Business Overview
7.8.3 Pfizer Anti-depressant Drugs Major Product Offerings
7.8.4 Pfizer Anti-depressant Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Pfizer Key News & Latest Developments
7.9 Teva Pharmaceutical Industries
7.9.1 Teva Pharmaceutical Industries Company Summary
7.9.2 Teva Pharmaceutical Industries Business Overview
7.9.3 Teva Pharmaceutical Industries Anti-depressant Drugs Major Product Offerings
7.9.4 Teva Pharmaceutical Industries Anti-depressant Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Teva Pharmaceutical Industries Key News & Latest Developments
7.10 Takeda Pharmaceutical Company
7.10.1 Takeda Pharmaceutical Company Company Summary
7.10.2 Takeda Pharmaceutical Company Business Overview
7.10.3 Takeda Pharmaceutical Company Anti-depressant Drugs Major Product Offerings
7.10.4 Takeda Pharmaceutical Company Anti-depressant Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Takeda Pharmaceutical Company Key News & Latest Developments
7.11 AstraZeneca
7.11.1 AstraZeneca Company Summary
7.11.2 AstraZeneca Anti-depressant Drugs Business Overview
7.11.3 AstraZeneca Anti-depressant Drugs Major Product Offerings
7.11.4 AstraZeneca Anti-depressant Drugs Sales and Revenue in Global (2018-2023)
7.11.5 AstraZeneca Key News & Latest Developments
7.12 Johnson and Johnson
7.12.1 Johnson and Johnson Company Summary
7.12.2 Johnson and Johnson Anti-depressant Drugs Business Overview
7.12.3 Johnson and Johnson Anti-depressant Drugs Major Product Offerings
7.12.4 Johnson and Johnson Anti-depressant Drugs Sales and Revenue in Global (2018-2023)
7.12.5 Johnson and Johnson Key News & Latest Developments
7.13 Sanofi
7.13.1 Sanofi Company Summary
7.13.2 Sanofi Anti-depressant Drugs Business Overview
7.13.3 Sanofi Anti-depressant Drugs Major Product Offerings
7.13.4 Sanofi Anti-depressant Drugs Sales and Revenue in Global (2018-2023)
7.13.5 Sanofi Key News & Latest Developments
7.14 Sun Pharmaceuticals
7.14.1 Sun Pharmaceuticals Company Summary
7.14.2 Sun Pharmaceuticals Business Overview
7.14.3 Sun Pharmaceuticals Anti-depressant Drugs Major Product Offerings
7.14.4 Sun Pharmaceuticals Anti-depressant Drugs Sales and Revenue in Global (2018-2023)
7.14.5 Sun Pharmaceuticals Key News & Latest Developments
8 Global Anti-depressant Drugs Production Capacity, Analysis
8.1 Global Anti-depressant Drugs Production Capacity, 2018-2029
8.2 Anti-depressant Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Anti-depressant Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Anti-depressant Drugs Supply Chain Analysis
10.1 Anti-depressant Drugs Industry Value Chain
10.2 Anti-depressant Drugs Upstream Market
10.3 Anti-depressant Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Anti-depressant Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Anti-depressant Drugs in Global Market
Table 2. Top Anti-depressant Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Anti-depressant Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Anti-depressant Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Anti-depressant Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Anti-depressant Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Anti-depressant Drugs Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Anti-depressant Drugs Product Type
Table 9. List of Global Tier 1 Anti-depressant Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti-depressant Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Anti-depressant Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Anti-depressant Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Anti-depressant Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Anti-depressant Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Anti-depressant Drugs Sales (K Units), 2024-2029
Table 16. By Application – Global Anti-depressant Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Anti-depressant Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Anti-depressant Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Anti-depressant Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Anti-depressant Drugs Sales (K Units), 2024-2029
Table 21. By Region – Global Anti-depressant Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Anti-depressant Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Anti-depressant Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Anti-depressant Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Anti-depressant Drugs Sales (K Units), 2024-2029
Table 26. By Country - North America Anti-depressant Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Anti-depressant Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Anti-depressant Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Anti-depressant Drugs Sales, (K Units), 2024-2029
Table 30. By Country - Europe Anti-depressant Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Anti-depressant Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Anti-depressant Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Anti-depressant Drugs Sales, (K Units), 2024-2029
Table 34. By Region - Asia Anti-depressant Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Anti-depressant Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Anti-depressant Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Anti-depressant Drugs Sales, (K Units), 2024-2029
Table 38. By Country - South America Anti-depressant Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Anti-depressant Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Anti-depressant Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Anti-depressant Drugs Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Anti-depressant Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Anti-depressant Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Anti-depressant Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Anti-depressant Drugs Sales, (K Units), 2024-2029
Table 46. Alkermes Company Summary
Table 47. Alkermes Anti-depressant Drugs Product Offerings
Table 48. Alkermes Anti-depressant Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Alkermes Key News & Latest Developments
Table 50. Allergan Company Summary
Table 51. Allergan Anti-depressant Drugs Product Offerings
Table 52. Allergan Anti-depressant Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Allergan Key News & Latest Developments
Table 54. Bristol-Myers Squibb Company Summary
Table 55. Bristol-Myers Squibb Anti-depressant Drugs Product Offerings
Table 56. Bristol-Myers Squibb Anti-depressant Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Bristol-Myers Squibb Key News & Latest Developments
Table 58. Eli Lilly and Company Company Summary
Table 59. Eli Lilly and Company Anti-depressant Drugs Product Offerings
Table 60. Eli Lilly and Company Anti-depressant Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Eli Lilly and Company Key News & Latest Developments
Table 62. GlaxoSmithKline Company Summary
Table 63. GlaxoSmithKline Anti-depressant Drugs Product Offerings
Table 64. GlaxoSmithKline Anti-depressant Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. GlaxoSmithKline Key News & Latest Developments
Table 66. Lundbeck Company Summary
Table 67. Lundbeck Anti-depressant Drugs Product Offerings
Table 68. Lundbeck Anti-depressant Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Lundbeck Key News & Latest Developments
Table 70. Merck Company Summary
Table 71. Merck Anti-depressant Drugs Product Offerings
Table 72. Merck Anti-depressant Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Merck Key News & Latest Developments
Table 74. Pfizer Company Summary
Table 75. Pfizer Anti-depressant Drugs Product Offerings
Table 76. Pfizer Anti-depressant Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Pfizer Key News & Latest Developments
Table 78. Teva Pharmaceutical Industries Company Summary
Table 79. Teva Pharmaceutical Industries Anti-depressant Drugs Product Offerings
Table 80. Teva Pharmaceutical Industries Anti-depressant Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. Teva Pharmaceutical Industries Key News & Latest Developments
Table 82. Takeda Pharmaceutical Company Company Summary
Table 83. Takeda Pharmaceutical Company Anti-depressant Drugs Product Offerings
Table 84. Takeda Pharmaceutical Company Anti-depressant Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 85. Takeda Pharmaceutical Company Key News & Latest Developments
Table 86. AstraZeneca Company Summary
Table 87. AstraZeneca Anti-depressant Drugs Product Offerings
Table 88. AstraZeneca Anti-depressant Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 89. AstraZeneca Key News & Latest Developments
Table 90. Johnson and Johnson Company Summary
Table 91. Johnson and Johnson Anti-depressant Drugs Product Offerings
Table 92. Johnson and Johnson Anti-depressant Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 93. Johnson and Johnson Key News & Latest Developments
Table 94. Sanofi Company Summary
Table 95. Sanofi Anti-depressant Drugs Product Offerings
Table 96. Sanofi Anti-depressant Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 97. Sanofi Key News & Latest Developments
Table 98. Sun Pharmaceuticals Company Summary
Table 99. Sun Pharmaceuticals Anti-depressant Drugs Product Offerings
Table 100. Sun Pharmaceuticals Anti-depressant Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 101. Sun Pharmaceuticals Key News & Latest Developments
Table 102. Anti-depressant Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 103. Global Anti-depressant Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 104. Global Anti-depressant Drugs Production by Region, 2018-2023 (K Units)
Table 105. Global Anti-depressant Drugs Production by Region, 2024-2029 (K Units)
Table 106. Anti-depressant Drugs Market Opportunities & Trends in Global Market
Table 107. Anti-depressant Drugs Market Drivers in Global Market
Table 108. Anti-depressant Drugs Market Restraints in Global Market
Table 109. Anti-depressant Drugs Raw Materials
Table 110. Anti-depressant Drugs Raw Materials Suppliers in Global Market
Table 111. Typical Anti-depressant Drugs Downstream
Table 112. Anti-depressant Drugs Downstream Clients in Global Market
Table 113. Anti-depressant Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Anti-depressant Drugs Segment by Type in 2022
Figure 2. Anti-depressant Drugs Segment by Application in 2022
Figure 3. Global Anti-depressant Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Anti-depressant Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Anti-depressant Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Anti-depressant Drugs Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Anti-depressant Drugs Revenue in 2022
Figure 9. By Type - Global Anti-depressant Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Anti-depressant Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Anti-depressant Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Anti-depressant Drugs Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Anti-depressant Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Anti-depressant Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Anti-depressant Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Anti-depressant Drugs Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Anti-depressant Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Anti-depressant Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Anti-depressant Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Anti-depressant Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Anti-depressant Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Anti-depressant Drugs Sales Market Share, 2018-2029
Figure 23. US Anti-depressant Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Anti-depressant Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Anti-depressant Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Anti-depressant Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Anti-depressant Drugs Sales Market Share, 2018-2029
Figure 28. Germany Anti-depressant Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Anti-depressant Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Anti-depressant Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Anti-depressant Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Anti-depressant Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Anti-depressant Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Anti-depressant Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Anti-depressant Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Anti-depressant Drugs Sales Market Share, 2018-2029
Figure 37. China Anti-depressant Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Anti-depressant Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Anti-depressant Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Anti-depressant Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Anti-depressant Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Anti-depressant Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Anti-depressant Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Anti-depressant Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Anti-depressant Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Anti-depressant Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Anti-depressant Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Anti-depressant Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Anti-depressant Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Anti-depressant Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Anti-depressant Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Anti-depressant Drugs Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Anti-depressant Drugs by Region, 2022 VS 2029
Figure 54. Anti-depressant Drugs Industry Value Chain
Figure 55. Marketing Channels

※参考情報

抗うつ剤（こううつざい）は、うつ病やその他の気分障害を治療するために使用される医薬品の一種です。これらの薬剤は、脳内の神経伝達物質のバランスを調整し、患者の気分を改善することを目的としています。抗うつ剤は多様な種類があり、それぞれ独自の作用メカニズムや副作用があります。

抗うつ剤の主な特徴は、その効果が即座に現れない点です。多くの抗うつ剤は数週間の服用が必要で、症状の改善を実感するまでに時間がかかることがあります。このため、患者は医師の指導のもと、規定の用量を守りながら継続して服用することが重要です。また、抗うつ剤には副作用があるため、これらのリスクを理解した上で服用する必要があります。

抗うつ剤の種類には、以下のようなものがあります。まず最も一般的なものが選択的セロトニン再取り込み阻害薬（SSRI）です。SSRIは脳内のセロトニン濃度を増やすことで気分を安定させる効果があります。フルオキセチン（プロザック）、セルトラリン（Zoloft）、エスシタロプラム（レクサプロ）などがこのカテゴリーに含まれます。

次に、セロトニン・ノルエピネフリン再取り込み阻害薬（SNRI）があります。これはセロトニンやノルエピネフリンの濃度を上昇させ、より強力な効果を持つとされています。デュロキセチン（サンボン）やベンラファキシン（エフェクソール）がこのクラスの例です。

また、三環系抗うつ薬（TCA）は、古いタイプの抗うつ剤ですが、依然として使用されています。アミトリプチリンやノルトリプチリンなどが該当します。これらは効果的ではありますが、副作用が強いため、一般的には他の新しい薬が優先される傾向にあります。

モノアミン酸化酵素阻害薬（MAOI）も抗うつ剤の一種です。この薬剤は脳内のモノアミンという神経伝達物質の効果を高めるもので、特に重度のうつ病に対して効果があります。ただし、MAOIは特定の食品や薬剤との相互作用が強く、使用にあたっては慎重な管理が必要です。

抗うつ剤は、うつ病以外にもいくつかの用途があります。たとえば、強迫性障害やパニック障害、社会不安障害、 PTSD（心的外傷後ストレス障害）などの治療にも用いられることがあります。また、痛みの管理や摂食障害、過敏性腸症候群（IBS）など、他の疾患の治療に有効とされる場合もあります。

最近では、抗うつ剤に加えて、心理療法の併用が一般的な治療法とされています。医師や心理士と連携しながら、薬剤治療と心理療法を組み合わせることで、より効果的に症状を緩和することが期待されます。

抗うつ剤の投与にあたっては、個々の患者の状態や病歴に基づいて慎重に判断する必要があります。効果がある一方で、副作用が現れることも多く、例えば、眠気、口渇、体重増加、性機能の低下などが報告されています。特に、若年者においては、自殺念慮や自殺行動のリスクが高まる可能性があるため、注意深い観察が求められます。

最近の研究では、抗うつ剤とともに新しい治療法も注目されています。例えば、経頭蓋磁気刺激（TMS）や心理的な介入としてのマインドフルネスなどが、抗うつ剤の効果を高める手段として研究されています。これらの治療法は、患者の気分やストレスの管理に寄与する可能性があります。

抗うつ剤はその効果や副作用を理解した上で使用されるべきであり、自己判断で服用を中止したり、変更したりすることは避けるべきです。また、治療の経過を定期的に医師と相談しながら見直すことが、より良い治療結果をもたらすでしょう。

抗うつ剤の使用にあたっては、他の薬剤との相互作用にも注意が必要です。特に、イブプロフェンやアスピリン、抗生物質などとの併用によって、薬剤の効果が強まったり、逆に弱まったりすることがあります。元々の病歴や現在服用している薬剤を詳細に医師に伝えることが重要です。

このように、抗うつ剤は多岐にわたる特性や用途を有していますが、個々の患者によって効果は異なります。したがって、常に医師の指導のもとで正しい使い方と効果的な治療計画の構築が求められます。これからの研究によって、さらなる効果的な治療法が開発され、より多くの患者が恩恵を受けることが期待されます。心の健康は非常に重要なものであり、適切な治療とサポートが必要です。以上が、抗うつ剤に関する基本的な情報となります。

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 抗うつ剤の世界市場見通し2023年-2029年(Anti-depressant Drugs Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

抗うつ剤の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp